• 1
    Turk D. Clinicians' attitudes about prolonged use of opioids and the issue of patient heterogeneity. J Pain Symptom Manage. 1996;11:21830.
  • 2
    Olt GJ. Managing pain and psychological issues in palliative care. Best Pract Res Clin Obstet Gynaecol. 2001;15:23551.
  • 3
    Warfield CA. Controlled-release morphine tablets in patients with chronic cancer pain: a narrative review of controlled clinical trials. Cancer. 1998;82:2299306.DOI: 10.1002/(sici)1097-0142(19980615)82:12<2299::aid-cncr1>;2-o
  • 4
    Mercadante S. World Health Organization Guidelines: problem areas in cancer pain management. Cancer Control. 1999;6:1917.
  • 5
    Walsh D. Pharmacological management of cancer pain. Semin Oncol. 2000;27:4563.
  • 6
    Grossman S, Sheidler V. Cancer pain. In: AbeloffMD, ed. Clinical Oncology, 2nd ed. New York: Churchill Livingstone, Inc. 2000; 5447.
  • 7
    American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA. 1995;274:187480.
  • 8
    Working Group of the Ethical Issues in Medicine Committee of the Royal College of Physicians. Principles of pain control in palliative care for adults. Guidance prepared by a Working Group of the Ethical Issues in Medicine Committee of the Royal College of Physicians. J Royal Coll Physicians. 2000;34:3502.
  • 9
    Abrahm JL. Management of pain and spinal cord compression in patients with advanced cancer. ACP-ASIM End-of-life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med. 1999;131:3746.
  • 10
    Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:1739.
  • 11
    Adams NJ, Plane MB, Fleming MF, Mundt MP, Saunders LA, Stauffacher EA. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001;22:7916.
  • 12
    Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13:11637.DOI: 10.1097/00002508-199706000-00006
  • 13
    Gallagher RM, Verma S. Managing pain and comorbid depression: a public health challenge. Semin Clin Neuropsychiatry. 1999;4:20320.
  • 14
    Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry. 2000;57:94550.
  • 15
    Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:7785.
  • 16
    Aronoff GM. Opioids in chronic pain management: is there a significant risk of addiction? Curr Rev Pain. 2000;4:11221.
  • 17
    Smith LC. Dual diagnosis. Effective recognition and management of severe mental illness and substance abuse. JAAPA 2001;14:224, 2730, 356.
  • 18
    Watkins KE, Burnam A, Kung FY, Paddock S. A national survey of care for persons with co-occurring mental and substance abuse disorders. Psychiatr Serv. 2001;52:10628.
  • 19
    Compton WM III, Cottler LB, Phelps DL, Ben Abdallah A, Spitznagel EL. Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addict. 2000;9:12634.
  • 20
    Lehman AF, Myers CP, Corty E. Assessment and clarification of patients with psychiatric and substance abuse syndromes. 1989. Psychiatr Serv. 2000;15:111925.
  • 21
    McCarberg BH, Barkin RL. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther. 2001;8:1816.
  • 22
    Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001;50:14551.
  • 23
    Turk DC, Brody MC, Okifuji EA. Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain. 1994;59:2018.
  • 24
    Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage. 1993;8:27988.
  • 25
    Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage. 1990;5(3):46S62S.
  • 26
    Sanders SH, Harden RN, Benson SE, Vicente PJ. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: An evidence-based approach. J Back Musculoskeletal Rehabil. 1999;13:4758.
  • 27
    Benjamin LJ, Dampier CC, Jacox AK, et al. Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease. [APS Clinical Practice Guideline Series No. 1]. Glenview, Ill: American Pain Society; 1999.
  • 28
    Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management. Chronic Pain Section. Anesthesiology. 1997;86:9951004.
  • 29
    Hagen N, Flynne P, Hays H, MacDonald N. Guidelines for managing chronic non-malignant pain. Opioids and other agents. College of Physicians and Surgeons of Alberta. Can Fam Physician. 1995;41:4953.
  • 30
    American Academy of Pain Medicine and American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement. Clin J Pain. 1997;13:68.
  • 31
    Portenoy R. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:20317.
  • 32
    Jamison RN. Comprehensive pretreatment and outcome assessment for chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage. 1996;11:23141.
  • 33
    Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:85360.
  • 34
    Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain. 2001;91:2331.DOI: 10.1016/s0304-3959(00)00414-0
  • 35
    Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine. 1998;23:2591600.DOI: 10.1097/00007632-199812010-00014
  • 36
    Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322:11548.
  • 37
    Dellemijn PL, Vanneste JA. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet. 1997;349:7538.
  • 38
    Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:183741.
  • 39
    Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z, Darke AC. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain. 1995;62:16978.DOI: 10.1016/0304-3959(94)00262-d
  • 40
    Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347:1437.
  • 41
    Tough P. The oxycontin underground: how a prescription painkiller is turning into a pernicious street drug. The New York Times Magazine. July 29, 2001:3163.